DE69921832D1 - Pharmazeutische zusammensetzungen mit antitumoraler wirkung auf basis von carboplatin - Google Patents

Pharmazeutische zusammensetzungen mit antitumoraler wirkung auf basis von carboplatin

Info

Publication number
DE69921832D1
DE69921832D1 DE69921832T DE69921832T DE69921832D1 DE 69921832 D1 DE69921832 D1 DE 69921832D1 DE 69921832 T DE69921832 T DE 69921832T DE 69921832 T DE69921832 T DE 69921832T DE 69921832 D1 DE69921832 D1 DE 69921832D1
Authority
DE
Germany
Prior art keywords
carboplatin
pharmaceutical compositions
effect based
antitumoral effect
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69921832T
Other languages
English (en)
Other versions
DE69921832T2 (de
Inventor
Vladimir Kysilka
Libuse Zatloukalova
Miroslav Malecek
Ronald Gust
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pliva Lachema AS
Original Assignee
Pliva Lachema AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Lachema AS filed Critical Pliva Lachema AS
Publication of DE69921832D1 publication Critical patent/DE69921832D1/de
Application granted granted Critical
Publication of DE69921832T2 publication Critical patent/DE69921832T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/0091—Complexes with metal-heteroatom-bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE69921832T 1998-08-14 1999-08-10 Pharmazeutische zusammensetzungen mit antitumoraler wirkung auf basis von carboplatin Expired - Lifetime DE69921832T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CZ19982588A CZ292170B6 (cs) 1998-08-14 1998-08-14 Farmaceutická kompozice s protinádorovým účinkem na bázi carboplatiny
CZ258898 1998-08-14
PCT/CZ1999/000028 WO2000009097A2 (en) 1998-08-14 1999-08-10 Pharmaceutical composition with antitumor activity on the basis of carboplatin

Publications (2)

Publication Number Publication Date
DE69921832D1 true DE69921832D1 (de) 2004-12-16
DE69921832T2 DE69921832T2 (de) 2005-11-03

Family

ID=5465233

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69921832T Expired - Lifetime DE69921832T2 (de) 1998-08-14 1999-08-10 Pharmazeutische zusammensetzungen mit antitumoraler wirkung auf basis von carboplatin

Country Status (17)

Country Link
US (1) US6589988B1 (de)
EP (1) EP1107750B1 (de)
AT (1) ATE281832T1 (de)
AU (1) AU5024599A (de)
BG (1) BG105207A (de)
CZ (1) CZ292170B6 (de)
DE (1) DE69921832T2 (de)
ES (1) ES2229737T3 (de)
HR (1) HRP20010110B1 (de)
HU (1) HUP0104304A3 (de)
NO (1) NO20010507L (de)
PL (1) PL346363A1 (de)
PT (1) PT1107750E (de)
RU (1) RU2188640C1 (de)
SK (1) SK284711B6 (de)
UA (1) UA73281C2 (de)
WO (1) WO2000009097A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100598474B1 (ko) 1998-04-03 2006-07-11 아지노모토 가부시키가이샤 항종양제
ATE430564T1 (de) * 2005-03-28 2009-05-15 Dabur Pharma Ltd Stabile pharmazeutische zusammensetzungen aus antitumoralen platin-(ii)-mitteln
KR101127159B1 (ko) * 2009-11-02 2012-03-20 한국생명공학연구원 식물병원성 그람음성 세균의 분비체계를 저해하는 카보프라틴 화합물을 유효성분으로 함유하는 식물병 방제제
EP3826613A4 (de) * 2018-08-31 2022-05-04 Sun Pharmaceutical Industries Limited Parenterale dosierungsform von carboplatin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS269719B1 (en) * 1986-12-29 1990-05-14 Kiss Frantisek Platinum cytostatic
JPH01146826A (ja) * 1987-12-03 1989-06-08 Nippon Kayaku Co Ltd 白金化合物の凍結乾燥製剤
US5455270A (en) * 1993-08-11 1995-10-03 Bristol-Myers Squibb Co. Stabilized solutions of platinum(II) antitumor agents
DE69427595T2 (de) * 1994-02-07 2002-04-25 Pliva Pharmaceutical Industry Antitumormittel auf basis von carboplatin und herstellung desselben

Also Published As

Publication number Publication date
NO20010507D0 (no) 2001-01-30
HRP20010110B1 (en) 2005-10-31
ES2229737T3 (es) 2005-04-16
HUP0104304A2 (hu) 2002-03-28
PT1107750E (pt) 2005-02-28
HUP0104304A3 (en) 2004-04-28
WO2000009097A2 (en) 2000-02-24
ATE281832T1 (de) 2004-11-15
SK284711B6 (sk) 2005-09-08
NO20010507L (no) 2001-01-30
EP1107750A2 (de) 2001-06-20
PL346363A1 (en) 2002-02-11
WO2000009097A3 (en) 2000-05-18
UA73281C2 (en) 2005-07-15
AU5024599A (en) 2000-03-06
CZ258898A3 (cs) 2000-02-16
RU2188640C1 (ru) 2002-09-10
BG105207A (en) 2001-07-31
SK2092001A3 (en) 2001-07-10
EP1107750B1 (de) 2004-11-10
CZ292170B6 (cs) 2003-08-13
US6589988B1 (en) 2003-07-08
DE69921832T2 (de) 2005-11-03
HRP20010110A2 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
BR0214757A (pt) Formulações farmacêuticas de derivados de platina
FR2451192A1 (fr) Agent de prevention de la mauvaise haleine contenant de la cyclodextrine
RS20050066A (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
RU94045798A (ru) Стереоизомеры итраконазола или саперконазола, способ их получения, их комплексы и способ получения, фармацевтическая композиция на их основе и ее получение, способ получения водных растворов с повышенной концентрацией итраконазола или саперконазола
IT1200589B (it) Derivati naturali attivita farmagologica
HRP20020198B1 (en) Moxifloxacin formulation containing common salt
ATE324039T1 (de) Verwendung von spinosad oder einer zusammensetzung enthaltend spinosad
TR200003688T1 (tr) Glutation'un absorbsıyonu'nun arttırılması ve etkilerinin güçlendirilmesi için kompozisyon
AU653371B2 (en) Pharmaceutical compositions
WO2004039326A3 (en) Propofol with cysteine
KR880007060A (ko) 제약 조성물
DE69921832D1 (de) Pharmazeutische zusammensetzungen mit antitumoraler wirkung auf basis von carboplatin
RU2001104352A (ru) Фармацевтическая композиция с противоопухолевой активностью на основе карбоплатина
DE60005469D1 (de) Arzneizusammensetzung enthaltend Ascorbinsäure und Pektin
KR910005886A (ko) 안정화 백혈구 인터페론
CA1283607C (en) Stable injectable pharmaceutical formulation for 1,4- dihydroxy-5-8-bis¬2-(2-hydroxyethylamino)-ethylamino| anthraquinone, dihydrochloride
DE69602208T2 (de) Stabilisierte pharmazeutische zusammensetzungen enthaltend dobutamine
TR200100887T2 (tr) LH-RH analoglarının ağız yoluyla verilmesi için alfa-siklodekstrin esaslı farmasötik terkipler
IT1302289B1 (it) Composizioni farmaceutiche ad attivita' antineoplastica
DE60003328D1 (de) Ruthenium (ii) komplexe mit hoher antitumor und antimetastatischer wirkung
KR900013959A (ko) γ-카르블린 또는 그들의 제약학적으로 허용 가능한 산부가염 및/또는 수화물, 및 그들로 구성되는 제약학적 조성물
UA33249A (uk) Диглюкозиламонієва сіль етилового ефіру 4-карбетоксиоксанілоілгідразиду щавлевої кислоти, яка проявляє протизапальну, аналгетичну, гастропротекторну та антибактеріальну активність
UA64074C2 (uk) Кардіопротекторний антиоксидантний засіб "елгацин"
RU2003114406A (ru) Витаминная композиция

Legal Events

Date Code Title Description
8364 No opposition during term of opposition